Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Laryngeal Mask Market Outlook (2022-2032)

[250 Pages Report] Newly-released Laryngeal Mask Market analysis report by Future Market Insights shows that global sales of Laryngeal Mask Market in 2021 was held at US$ 656.4 Million. With 7.9%, the projected market growth during 2022 to 2032 is expected to be significantly higher than the historical growth.

Disposable Laryngeal Masks is expected to be the highest revenue generating segment, projected to grow at a CAGR of over 7.9% during 2022 to 2032.

Attributes Details
Laryngeal Mask Market CAGR (2022 to 2032) 7.9%
Laryngeal Mask Market Size (2022) US$ 656.4 million
Laryngeal Mask Market Size (2032) US$ 1.5 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue Of Laryngeal Mask Market From 2017 To 2021 Compared To Demand Outlook For 2022 To 2032

According to the Laryngeal Mask Market study conducted by Future Market Insights, a market research and competitive intelligence company, the market value of the Laryngeal Mask Market rose at a CAGR of roughly 7.1% from 2017 to 2021.

The market for laryngeal masks is expected to expand in conjunction with technical advances, such as the use of mechanical ventilation in suitably fasting patients while limiting the inspiratory forces imposed. When compared to first-generation LMAs, second-generation devices may reduce leak and restrict stomach insufflation. Moreover, throughout the projected period, increased demand for airway laryngeal masks are likely to drive the demand.

The lower cost per patient with the usage of the laryngeal masks contributes to their increasing popularity. Furthermore, the widespread availability of reusable laryngeal masks drives the revenue. Besides, their simplicity of usage and lesser requirement of sanitization, maintenance, less space consuming characteristic and being cost effective increases their utility.

What Factors Are Propelling Laryngeal Mask Demand?

In the coming years, the overwhelming numbers of surgical operations for the management of chronic disorders such as chronic bronchitis and asthma is predicted to fuel consumer demand for laryngeal mask. A significant increase in the worldwide frequency of respiratory ailments such as chronic obstructive pulmonary disease, and acute respiratory distress syndrome is expected to offer growth prospects over the projected timeframe.

Similarly, higher supply for airway ventilated laryngeal masks is expected to raise demand during the forecast period. Disposable medical equipment are in high demand in critical care units such as Intensive care unit (ICU) or trauma centers which has been consequently pushing the demand for laryngeal mask.

Furthermore, the introduction of low-cost laryngeal masks and growing market penetration efforts by key competitors in different regions, is expected to boost the revenue for laryngeal mask market. Furthermore, the increased frequency of chronic conditions requiring anaesthetic operations is pushing the demand for laryngeal masks.

As per the Healthcare Insurance Reciprocal of Canada (HIROC) and the Canadian Medical Protective Association (CMPA) medico-legal, about 1 Mn operations are conducted each year, drives the laryngeal mask demand.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Category Of The Laryngeal Mask Market Grew The Fastest, Based On End Use?

Based on end-user, hospitals and clinics held the largest revenue share of over 60.3% in the market for laryngeal masks in 2020. Mask for the larynx airway is extremely useful in pre-hospital situations, for treating problematic airways, apart from the patients suffering from cardiac arrest.

Outside of the hospital, an LMA can be implanted for effective airway control until a permanent airway can be established. Due to the ease of accessibility and usage of attractive compensation schemes such as Medicare and Blue Cross Blue Shield, the segment will maintain its leading position during the predicted period. As a consequence, the worldwide market for laryngeal masks is predicted to grow at a fast pace in the coming years.

Which Region Is Projected To Offer The Largest Opportunity For Laryngeal Mask Market?

North America is likely to dominate the laryngeal mask market in the future years, owing to factors such as enhanced healthcare infrastructure and increase in the incidence of respiratory ailments like asthma. In addition, growing anaesthetic usage during surgeries is further driving the demand for laryngeal masks. Market growth is also attributed to standard regulatory regulations such as the compulsion to use masks during Covid in the region.

In contrast, the market in Asia Pacific is predicted to develop at the faster rate as compared to other regions over the forthcoming decade. The growth in revenue can be attributed to various factors including increase in the number of elderly population, and active involvement of industry participants like Medtronic Plc, Teleflex Inc., Intersurgical Ltd. towards increasing focus on the region's emerging countries.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-Wise Analysis

Which Country Lies at the CenterStage for Laryngeal Mask Market Revenue?

The United States is a large global market for laryngeal masks. Over the forecast period, the laryngeal mask market in the United States is expected to witness significant boom. The country’s laryngeal mask market is fueled by growing elderly population and chronic illnesses.

Category-Wise Insights

Why Disposable Laryngeal Masks is projected to Witness Fastest Growth among Laryngeal Mask Type?

During 2022-2032, disposable laryngeal masks market is expected to increase at a CAGR of about 7.9%. It provides patients with a pleasant airway while also removing the risk of disease transmission because it is not reused.

Furthermore, under nitrous oxide anaesthesia, laryngeal masks have a rather steady intracuff pressure. The disposable laryngeal mask is designed to be used as an alternative to a facemask for attaining and maintaining airway control in patients during normal and emergency anaesthetic treatments.

The decreased cost per patient associated with the usage of these masks can be attributable to their greater utilisation. Furthermore, owing to their cost effectiveness, their volume sales is on surge. These factors are likely to attract developing enterprises with limited capital resources to enter the market.

Why Laryngeal Masks Market garner high revenues through adults segment?

Revenue through Adults segment is expected to command significant revenue as well as a CAGR of approximately 8.1% in the Laryngeal Mask Market over the projection period. Because of the growing number of operations and the high incidence of chronic illnesses amongst adulthood, the segment is likely continue to grow at a constant CAGR.

Based on World Center for Environmental Research and Public Health, more than half of all Americans have chronic illness. The impact of chronic diseases on the laryngeal mask business in the near future is depicted to boost the market.

What is the impact of Covid-19 on Laryngeal Mask Market?

The COVID-19 pandemic is still harming many businesses' growth, and the outbreak's early signs are varied. Laryngeal masks were seen as a substitute to mask anesthetic and endotracheal intubation for surgical operations and the treatments of difficult airways.

Anaesthetists are more susceptible to infection when they perform aerosol-generating airway operations on a regular basis. This led in a slow adoption of laryngeal covers during the epidemic. Several anaesthetic essential management approaches had also been suggested due to the coronavirus epidemic. Some essential management approaches included safeguarding clinical staff and reducing aerosol emission.

Competitive Analysis

The industry for laryngeal masks is being driven by a rise in medical procedures coupled with an expansion in disposable mask demands. Several mid-size and smaller enterprises are growing their market presence by offering laryngeal masks at cheaper pricing.

Some of the recent developments of key Laryngeal Mask providers are as follows:

  • In February 2021, Ambu A/S announced to expand its single-use endoscopy contracts with two major US Group Purchasing Organizations.
  • In May 2019, Ambu A/S signed a strategic partnership with Cook Medical, under which Cook Medical would distribute Ambu's products in the United States.

Similarly, recent developments related to companies Laryngeal Mask services have been tracked by the team at Future Market Insights, which are available in the full report.

Laryngeal Mask Market Report Scope

Attribute Details
Forecast Period 2022 to 2032
Historical Data Available for 2017 to 2021
Market Analysis US$ Million for Value
Key Regions Covered North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, South Africa, Saudi Arabia, UAE and Israel.
Key Market Segments Covered Product Type, Patient, End Uses, Region
Key Companies Profiled
  • Ambu A/S
  • BLS Systems
  • Medtronic
  • Hsiner Co. Ltd
  • Thermo Fisher
  • Cardinal Health
  • Smiths Group plc
  • Intersurgical
  • Teleflex Incorporated
  • Ferno
Pricing Available upon Request

Market Segments Covered In Laryngeal Mask Market Analysis

By Product Type:

  • Reusable Laryngeal Masks
  • Disposable Laryngeal Masks

By Patient:

  • Children
  • Adult
  • Geriatric

By End-use:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Frequently Asked Questions

How much is the current worth of the Laryngeal Mask Market?

The global Laryngeal Mask Market is worth more than US$ 656.4 Mn at present.

What is the sales forecast for Laryngeal Mask Market?

Value of Laryngeal Mask Market are projected to increase at a CAGR of around 7.9% during 2022 – 2032.

What was the last 5 year’s market CAGR?

Value of Laryngeal Mask Market increased at a CAGR of around 7.1% during 2017 – 2021.

What is a key trend shaping the growth of the market for Laryngeal Mask Market?

The rising number of surgical operations, technical advancements, the prevalence of chronic respiratory disorders, and the ageing population are all propelling the laryngeal mask market forward.

At what percentage is sales of Laryngeal Mask Market going to register growth in China?

The market for Laryngeal Mask Market in China is projected to expand at a CAGR of around 9.6% during 2022 – 2032.

What do statistics for South Korea and Japan reveal?

While the market in South Korea is expected to grow at nearly 8.3%, the market in Japan is projected to register a CAGR of nearly 10.1% during 2022 - 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Reusable Laryngeal Masks

        5.3.2. Disposable Laryngeal Masks

        5.3.3. Laparoscopic Diagnostic Procedures

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Patient

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Patient, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Patient, 2022-2032

        6.3.1. Children

        6.3.2. Adult

        6.3.3. Geriatric

    6.4. Y-o-Y Growth Trend Analysis By Patient, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Patient, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End Use

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End Use, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Use, 2022-2032

        7.3.1. Hositals and Clinics

        7.3.2. Ambulatiry Surgical Centers

    7.4. Y-o-Y Growth Trend Analysis By End Use, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End Use, 2022-2032

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Patient

        9.2.4. By End Use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Patient

        9.3.4. By End Use

    9.4. Key Takeaways

10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Patient

        10.2.4. By End Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Patient

        10.3.4. By End Use

    10.4. Key Takeaways

11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. Russia

            11.2.1.7. BENELUX

            11.2.1.8. Rest of Europe

        11.2.2. By Product Type

        11.2.3. By Patient

        11.2.4. By End Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Patient

        11.3.4. By End Use

    11.4. Key Takeaways

12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Rest of Asia Pacific

        12.2.2. By Product Type

        12.2.3. By Patient

        12.2.4. By End Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Patient

        12.3.4. By End Use

    12.4. Key Takeaways

13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC

            13.2.1.2. Rest of MEA

        13.2.2. By Product Type

        13.2.3. By Patient

        13.2.4. By End Use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Patient

        13.3.4. By End Use

    13.4. Key Takeaways

14. Key Countries Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Product Type

            14.1.2.2. By Patient

            14.1.2.3. By End Use

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Product Type

            14.2.2.2. By Patient

            14.2.2.3. By End Use

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Product Type

            14.3.2.2. By Patient

            14.3.2.3. By End Use

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Product Type

            14.4.2.2. By Patient

            14.4.2.3. By End Use

    14.5. Argentina

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Product Type

            14.5.2.2. By Patient

            14.5.2.3. By End Use

    14.6. Germany

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Product Type

            14.6.2.2. By Patient

            14.6.2.3. By End Use

    14.7. Italy

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Product Type

            14.7.2.2. By Patient

            14.7.2.3. By End Use

    14.8. France

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Product Type

            14.8.2.2. By Patient

            14.8.2.3. By End Use

    14.9. U.K.

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Product Type

            14.9.2.2. By Patient

            14.9.2.3. By End Use

    14.10. Spain

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Product Type

            14.10.2.2. By Patient

            14.10.2.3. By End Use

    14.11. Russia

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Product Type

            14.11.2.2. By Patient

            14.11.2.3. By End Use

    14.12. BENELUX

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Product Type

            14.12.2.2. By Patient

            14.12.2.3. By End Use

    14.13. China

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Product Type

            14.13.2.2. By Patient

            14.13.2.3. By End Use

    14.14. Japan

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Product Type

            14.14.2.2. By Patient

            14.14.2.3. By End Use

    14.15. South Korea

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Product Type

            14.15.2.2. By Patient

            14.15.2.3. By End Use

    14.16. India

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Product Type

            14.16.2.2. By Patient

            14.16.2.3. By End Use

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Product Type

            14.17.2.2. By Patient

            14.17.2.3. By End Use

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Product Type

        15.3.3. By Patient

        15.3.4. By End Use

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Ambu A/S

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segment

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

                16.1.1.5.2. Product Strategy

        16.1.2. BLS Systems

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segment

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

                16.1.2.5.2. Product Strategy

        16.1.3. Medtronic

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segment

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

                16.1.3.5.2. Product Strategy

        16.1.4. Hsiner Co. Ltd.

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segment

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

                16.1.4.5.2. Product Strategy

        16.1.5. Thermo Fisher

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segment

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

                16.1.5.5.2. Product Strategy

        16.1.6. Cardinal Health

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segment

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

                16.1.6.5.2. Product Strategy

        16.1.7. Smiths Group plc

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segment

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

                16.1.7.5.2. Product Strategy

        16.1.8. Intersurgical

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segment

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

                16.1.8.5.2. Product Strategy

        16.1.9. Telefelx Incorporated

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segment

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

                16.1.9.5.2. Product Strategy

        16.1.10. Ferno

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segment

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

                16.1.10.5.2. Product Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Explore Healthcare Insights

View Reports